BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 35201491)

  • 1. Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma.
    Zhang L; Hu S; Chen J; Ma S; Liu F; Liu C; Gao Y
    Discov Oncol; 2021 Oct; 12(1):38. PubMed ID: 35201491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p/YWHAZ axis.
    Shen X; Ding Y; Lu F; Yuan H; Luan W
    Am J Transl Res; 2020; 12(10):6381-6394. PubMed ID: 33194037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of circRNA-Based ceRNA Network to Reveal the Role of circRNAs in the Progression and Prognosis of Hepatocellular Carcinoma.
    Deng R; Cui X; Dong Y; Tang Y; Tao X; Wang S; Wang J; Chen L
    Front Genet; 2021; 12():626764. PubMed ID: 33719338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stellate cell-released CXCL1 aggravates HCC malignant behaviors through the MIR4435-2HG/miR-506-3p/TGFB1 axis.
    Li S; Hu X; Yu S; Yi P; Chen R; Huang Z; Huang Y; Huang Y; Zhou R; Fan X
    Cancer Sci; 2023 Feb; 114(2):504-520. PubMed ID: 36169092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma.
    Hu S; Zhang J; Guo G; Zhang L; Dai J; Gao Y
    PLoS One; 2022; 17(4):e0267117. PubMed ID: 35482720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of lncRNA-mediated ceRNA networkfor hepatocellular carcinoma.
    Chen W; Chen F; Gong M; Jin Z; Shu L; Wang ZW; Wang J
    Front Oncol; 2022; 12():1042928. PubMed ID: 36338699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and Analysis of Immune Infiltration-Related ceRNA Network for Kidney Stones.
    Xia Y; Zhou X; Ye Z; Yu W; Ning J; Ruan Y; Yuan R; Lin F; Ye P; Zheng D; Rao T; Cheng F
    Front Genet; 2021; 12():774155. PubMed ID: 34938320
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer.
    Chen J; Song Y; Li M; Zhang Y; Lin T; Sun J; Wang D; Liu Y; Guo J; Yu W
    BMC Cancer; 2021 Mar; 21(1):255. PubMed ID: 33750326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma.
    Tang Y; Zhang H; Chen L; Zhang T; Xu N; Huang Z
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lncRNA-miRNA-mRNA ceRNA network in mural granulosa cells of patients with polycystic ovary syndrome: an analysis of Gene Expression Omnibus data.
    Chen H; Cheng S; Xiong W; Tan X
    Ann Transl Med; 2021 Jul; 9(14):1156. PubMed ID: 34430597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of MIR4435-2HG Suppresses the Proliferation, Migration and Invasion of Cervical Cancer Cells via Regulating the miR-128-3p/MSI2 Axis in vitro.
    Wang R; Liu L; Jiao J; Gao D
    Cancer Manag Res; 2020; 12():8745-8756. PubMed ID: 33061572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.
    Gao LF; Li W; Liu YG; Zhang C; Gao WN; Wang L
    Front Oncol; 2021; 11():661288. PubMed ID: 34532282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma.
    Zhang DD; Shi Y; Liu JB; Yang XL; Xin R; Wang HM; Wang PY; Jia CY; Zhang WJ; Ma YS; Fu D
    Mol Ther Nucleic Acids; 2021 Jun; 24():1033-1050. PubMed ID: 34141458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.
    Ke J; Wang Q; Zhang W; Ni S; Mei H
    Am J Transl Res; 2022; 14(8):5441-5454. PubMed ID: 36105009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
    Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
    Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma.
    Xu Z; Pei C; Cheng H; Song K; Yang J; Li Y; He Y; Liang W; Liu B; Tan W; Li X; Pan X; Meng L
    Front Immunol; 2023; 14():1138524. PubMed ID: 37234166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Integrated analysis of DNA methylation and gene expression profiles of hepatocellular carcinoma to construct miR-1180-3p relevant ceRNA regulatory network].
    Zhou ZH; Zhou XG; Zhou ZW; Qiu MQ; Jiang YJ; Lin QL; Liu YC; Wen QP; Huo RR; Liang XM; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):481-487. PubMed ID: 32660176
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Hepatocellular Carcinoma With Vascular Invasion.
    Cai S; Du R; Zhang Y; Yuan Z; Shang J; Yang Y; Han B; Zhong W; Yuan H; Li Z
    Front Bioinform; 2022; 2():836981. PubMed ID: 36304284
    [No Abstract]   [Full Text] [Related]  

  • 19. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma.
    Zhan T; Gao X; Wang G; Li F; Shen J; Lu C; Xu L; Li Y; Zhang J
    Front Oncol; 2021; 11():626663. PubMed ID: 34336642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.